FI59101C - Foerfarande foer framstaellning av antibakteriella 3-(substituerad amino)tolypomycinoner 3-(substituerad amino)-16,17-dihydrotolypomycinoner och 3,16-di(substituerad amino)-16,17-dihydrotolypomycinoner - Google Patents

Foerfarande foer framstaellning av antibakteriella 3-(substituerad amino)tolypomycinoner 3-(substituerad amino)-16,17-dihydrotolypomycinoner och 3,16-di(substituerad amino)-16,17-dihydrotolypomycinoner Download PDF

Info

Publication number
FI59101C
FI59101C FI750743A FI750743A FI59101C FI 59101 C FI59101 C FI 59101C FI 750743 A FI750743 A FI 750743A FI 750743 A FI750743 A FI 750743A FI 59101 C FI59101 C FI 59101C
Authority
FI
Finland
Prior art keywords
chloroform
added
evaporated
water
silica gel
Prior art date
Application number
FI750743A
Other languages
English (en)
Finnish (fi)
Other versions
FI59101B (fi
FI750743A (nl
Inventor
Mario Brufani
Egidio Marchi
Giuseppe Mascellani
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB1167474A external-priority patent/GB1498033A/en
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of FI750743A publication Critical patent/FI750743A/fi
Application granted granted Critical
Publication of FI59101B publication Critical patent/FI59101B/fi
Publication of FI59101C publication Critical patent/FI59101C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
FI750743A 1974-03-15 1975-03-14 Foerfarande foer framstaellning av antibakteriella 3-(substituerad amino)tolypomycinoner 3-(substituerad amino)-16,17-dihydrotolypomycinoner och 3,16-di(substituerad amino)-16,17-dihydrotolypomycinoner FI59101C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1167474 1974-03-15
GB1167474A GB1498033A (en) 1974-03-15 1974-03-15 Tolypomycinone derivatives and process for their preparation
GB4739874 1974-11-01
GB4739874 1974-11-01

Publications (3)

Publication Number Publication Date
FI750743A FI750743A (nl) 1975-09-16
FI59101B FI59101B (fi) 1981-02-27
FI59101C true FI59101C (fi) 1981-06-10

Family

ID=26248441

Family Applications (1)

Application Number Title Priority Date Filing Date
FI750743A FI59101C (fi) 1974-03-15 1975-03-14 Foerfarande foer framstaellning av antibakteriella 3-(substituerad amino)tolypomycinoner 3-(substituerad amino)-16,17-dihydrotolypomycinoner och 3,16-di(substituerad amino)-16,17-dihydrotolypomycinoner

Country Status (14)

Country Link
JP (1) JPS5341680B2 (nl)
AR (2) AR208540A1 (nl)
AT (1) AT335610B (nl)
CA (1) CA1063604A (nl)
DE (1) DE2510931A1 (nl)
DK (1) DK104075A (nl)
ES (1) ES435620A1 (nl)
FI (1) FI59101C (nl)
FR (1) FR2263767A1 (nl)
IT (1) IT1060152B (nl)
LU (1) LU72029A1 (nl)
NL (1) NL159986C (nl)
PH (1) PH13558A (nl)
SE (1) SE7502882L (nl)

Also Published As

Publication number Publication date
DK104075A (nl) 1975-09-16
NL159986C (nl) 1979-09-17
PH13558A (en) 1980-06-26
IT1060152B (it) 1982-07-10
SE7502882L (sv) 1975-09-16
LU72029A1 (nl) 1976-02-04
NL7502980A (nl) 1975-09-17
ATA195975A (de) 1976-07-15
AT335610B (de) 1977-03-25
JPS50157399A (nl) 1975-12-19
FI59101B (fi) 1981-02-27
ES435620A1 (es) 1977-05-01
DE2510931A1 (de) 1975-11-13
NL159986B (nl) 1979-04-17
CA1063604A (en) 1979-10-02
AR213283A1 (es) 1979-01-15
FI750743A (nl) 1975-09-16
FR2263767B1 (nl) 1980-01-04
FR2263767A1 (en) 1975-10-10
AR208540A1 (es) 1977-02-15
JPS5341680B2 (nl) 1978-11-06

Similar Documents

Publication Publication Date Title
FI63244C (fi) Foerfarande foer framstaellning av antibakteriska erytromysinderivater
EP0312858A1 (en) Heterocyclic derivatives, their preparation and radiosensitizing agents and antiviral agents comprising same as their active component
US4056322A (en) Preparation of ethers of monosaccharides
EP0118913B1 (en) Porphyrin derivatives
CA1112649A (en) 4-spectinomycylamine and salts thereof
CN114874204A (zh) 靶向SARS-CoV-2 3C蛋白酶的PROTAC分子及其应用
DK153795B (da) Analogifremgangsmaade til fremstilling af 20-deoxo-tylosin-macrolid-derivater eller farmaceutisk acceptable salte
EP0047323B1 (en) 1,4-naphthoquinone derivatives and use thereof
FI59101C (fi) Foerfarande foer framstaellning av antibakteriella 3-(substituerad amino)tolypomycinoner 3-(substituerad amino)-16,17-dihydrotolypomycinoner och 3,16-di(substituerad amino)-16,17-dihydrotolypomycinoner
FI80046C (fi) Foerfarande foer separering av ett primycinantibiotikakomplex.
NO143349B (no) Analogifremgangsmaate for fremstilling av nye derivater av daunorubicin
FR2458556A1 (fr) Derives de la paromomycine, procede pour les preparer et leur usage comme medicament
US4232023A (en) Novel soluble derivatives of 2,4-diamino pyrimidine
EP0005346B1 (en) Enterochelin complexes, pharmaceutical compositions containing them and a process for preparing them
KR900006234B1 (ko) 신규의 3', 4'-디니트로겐 치환 에피포도필로톡신 배당체의 유도체
IE45964B1 (en) Semi-synthetic oleandomycin derivatives - c8 modifications
US4472388A (en) N-Methanesulfonic acid derivatives of 3-O-demethylistamycin B and production thereof
KR930007263B1 (ko) 세프-3-엠-4-카르복실산 유도체의 제조방법
US3652535A (en) Kasugamycin derivatives
US4126616A (en) N-propylnorapomorphine diesters
US4576945A (en) Hexaalkylmelamine-amino-oxy compounds
US3914379A (en) Substituted (nitrofuryl-acrylidene) hydrazines with antibacterial properties
Naito et al. CEPHALOSPORINS. II 7-(O-AMINOMETHYLPHENYLACETAMIDO) CEPHALOSPORANIC ACIDS WITH SIX-MEMBERED HETEROCYCLES IN THE C-3 SIDE CHAIN
SU432721A3 (ru) Способ получения производных 3-формилрифамицина sv
EP0205168B1 (en) Furfuryl derivatives of vinblastine-type bis-indoles, a process for preparing same and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ALFA FARMACEUTICI, S.P.A.